Becton Dickinson and Co (NYSE:BDX)
| 239.30 Delayed Data As of May 07 |  -1.51 / -0.63%Today’s Change | 219.50 Today|||52-Week Range 284.97 | -4.36% Year-to-Date |
Latest BDX News | Press Releases
Today’s Trading
| Previous close | 240.81 |
| Today’s open | 241.49 |
| Day’s range | 238.98 - 244.80 |
| Volume | 2,548,304 |
| Average volume (3 months) | 1,316,765 |
| Market cap | $69.6B |
Data as of 4:00pm ET, 05/07/2021
Growth & Valuation
| Earnings growth (last year) | -31.44% |
| Earnings growth (this year) | +25.92% |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | -1.00% |
| P/E ratio | 46.1 |
| Price/Sales | 3.84 |
| Price/Book | 2.92 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BSXBoston Scientific Co... | +0.09 | +0.21% |
| BAXBaxter International... | -0.93 | -1.06% |
| ZBHZimmer Biomet Holdin... | -0.67 | -0.39% |
| DXCMDexcom Inc | +1.29 | +0.36% |
Data as of 4:00pm ET, 05/07/2021
Financials
| Next reporting date | August 12, 2021 |
| EPS forecast (this quarter) | $2.48 |
| Annual revenue (last year) | $17.1B |
| Annual profit (last year) | $874.0M |
| Net profit margin | 5.11% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Franklin Lakes, New Jersey |
Forecasts
